Low glycemic index ready-to-eat blenderized diet in retort pouch

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230622002

Enrollment

Registered

2023-06-22

Start date

2021-11-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood glucose Blood glucose, insulin resistance, Type 2 diabetes

Interventions

Glucose was a reference food that prepared by dissolved with 150 ml water.,STD was a standard formula ready-to-eat blenderized diet in retort pouch.,BD Test was a Low glycemic index ready-to-eat ble

Experimental Other,Experimental Other,Experimental Other

Glucose,STD ,BD Test

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Study A 1. Healthy and Normal BMI 18.5-22.9 kg/m2. 2. Not be a pregnant or lactation woman. 3. No smoking and alcohol drinking. 4. No history of food allergy or intolerance including eggs, isomaltulose, pumpkin, chicken. 5. No medications known to affect glucose tolerance (excluding oral contraceptives) Study B 1. Type 2 diabetes patients (less than 10 years) 2. Fasting blood glucose < 180 mg/dl. 3. BMI 18.5-30 kg/m2

Exclusion criteria

Exclusion criteria: Study A 1. A major medical or surgical event requiring hospitalization within the preceding 3 months; 2. Use of steroids, protease inhibitors or antipsychotics (all of which have major effects on glucose metabolism and body fat distribution). 3. History of disease/illness such as diabetes mellitus, liver disease, renal disease, thyroid disease, heart disease or others related to glucose metabolism Study B 1. Insulin treatment 2. People with disease as follow, chronic kidney disease, chronic pancreatic disease, thyroid disease or disease that affect glucose metabolism 3. Pregnant women 4. loss/gain weight more than 5 kg in 2 months 5. Glomerular Filtration Rate < 60 ml/min

Design outcomes

Primary

Measure	Time frame
Blood glucose Study A: At fasting state, 15, 30, 45, 60, 90 and 120 min after intake food. plasma glucose,Blood glucose Study B: At fasting state, 30, 60, 90, 120, 180 and 240 min after intake food. Plasma glucose	—

Secondary

Measure	Time frame
Blood insulin Study B: At fasting state, 30, 60, 90, 120, 180 and 240 min after intake food. Serum insulin	—

Countries

Thailand

Contacts

Public Contactsasiumphai purttiponthanee

Institute of Nutrition, Mahidol University

sasiumphai.pur@mahidol.ac.th028002380

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026